SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Novartis shares rise after multiple sclerosis pill hits trial goals

Novartis shares rose 4.5% in European midday trading Tuesday after the drugmaker reported positive results from two late-stage multiple sclerosis trials, saying its new pill reduced flare-ups.

NOT

Novartis shares rose 4.5% in European midday trading Tuesday after the drugmaker reported positive results from two late-stage trials in the most common form of multiple sclerosis. The company said its new pill helped patients experience fewer flare-ups.

Related stories